These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12814658)

  • 1. Targeting striatal cholinergic interneurons in Parkinson's disease: focus on metabotropic glutamate receptors.
    Pisani A; Bonsi P; Centonze D; Gubellini P; Bernardi G; Calabresi P
    Neuropharmacology; 2003 Jul; 45(1):45-56. PubMed ID: 12814658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease.
    Ztaou S; Amalric M
    Neurochem Int; 2019 Jun; 126():1-10. PubMed ID: 30825602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease.
    Bonsi P; Cuomo D; Picconi B; Sciamanna G; Tscherter A; Tolu M; Bernardi G; Calabresi P; Pisani A
    Amino Acids; 2007 Feb; 32(2):189-95. PubMed ID: 16715415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons.
    Pisani A; Bonsi P; Catania MV; Giuffrida R; Morari M; Marti M; Centonze D; Bernardi G; Kingston AE; Calabresi P
    J Neurosci; 2002 Jul; 22(14):6176-85. PubMed ID: 12122076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease.
    Tozzi A; de Iure A; Di Filippo M; Tantucci M; Costa C; Borsini F; Ghiglieri V; Giampà C; Fusco FR; Picconi B; Calabresi P
    J Neurosci; 2011 Feb; 31(5):1850-62. PubMed ID: 21289195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The striatal cholinergic system in L-dopa-induced dyskinesias.
    Perez XA; Bordia T; Quik M
    J Neural Transm (Vienna); 2018 Aug; 125(8):1251-1262. PubMed ID: 29492663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine Cells Differentially Regulate Striatal Cholinergic Transmission across Regions through Corelease of Dopamine and Glutamate.
    Cai Y; Ford CP
    Cell Rep; 2018 Dec; 25(11):3148-3157.e3. PubMed ID: 30540946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemogenetic modulation of cholinergic interneurons reveals their regulating role on the direct and indirect output pathways from the striatum.
    Aldrin-Kirk P; Heuer A; Rylander Ottosson D; Davidsson M; Mattsson B; Björklund T
    Neurobiol Dis; 2018 Jan; 109(Pt A):148-162. PubMed ID: 29037828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of dopamine D2 receptors on cholinergic interneurons of the dorsal striatum and nucleus accumbens of the rat.
    Alcantara AA; Chen V; Herring BE; Mendenhall JM; Berlanga ML
    Brain Res; 2003 Oct; 986(1-2):22-9. PubMed ID: 12965226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key role of striatal cholinergic interneurons in processes leading to arrest of motor stereotypies.
    Aliane V; Pérez S; Bohren Y; Deniau JM; Kemel ML
    Brain; 2011 Jan; 134(Pt 1):110-8. PubMed ID: 21097493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia.
    Sciamanna G; Ponterio G; Tassone A; Maltese M; Madeo G; Martella G; Poli S; Schirinzi T; Bonsi P; Pisani A
    Neuropharmacology; 2014 Oct; 85():440-50. PubMed ID: 24951854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons.
    Pisani A; Bonsi P; Centonze D; Calabresi P; Bernardi G
    J Neurosci; 2000 Apr; 20(7):RC69. PubMed ID: 10729358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is nicotine protective against Parkinson's disease? An experimental analysis.
    García-Montes JR; Boronat-García A; López-Colomé AM; Bargas J; Guerra-Crespo M; Drucker-Colín R
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):897-906. PubMed ID: 23131151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine Deficiency Reduces Striatal Cholinergic Interneuron Function in Models of Parkinson's Disease.
    McKinley JW; Shi Z; Kawikova I; Hur M; Bamford IJ; Sudarsana Devi SP; Vahedipour A; Darvas M; Bamford NS
    Neuron; 2019 Sep; 103(6):1056-1072.e6. PubMed ID: 31324539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Group-II metabotropic glutamate receptors negatively modulate NMDA transmission at striatal cholinergic terminals: role of P/Q-type high voltage activated Ca++ channels and endogenous dopamine.
    Mela F; Marti M; Fiorentini C; Missale C; Morari M
    Mol Cell Neurosci; 2006 Feb; 31(2):284-92. PubMed ID: 16249096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion.
    Ding J; Guzman JN; Tkatch T; Chen S; Goldberg JA; Ebert PJ; Levitt P; Wilson CJ; Hamm HE; Surmeier DJ
    Nat Neurosci; 2006 Jun; 9(6):832-42. PubMed ID: 16699510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
    Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M
    J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia.
    Pisani A; Martella G; Tscherter A; Bonsi P; Sharma N; Bernardi G; Standaert DG
    Neurobiol Dis; 2006 Nov; 24(2):318-25. PubMed ID: 16934985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of an afterhyperpolarization current increases excitability in striatal cholinergic interneurons in rat parkinsonism.
    Sanchez G; Rodriguez MJ; Pomata P; Rela L; Murer MG
    J Neurosci; 2011 Apr; 31(17):6553-64. PubMed ID: 21525296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal cholinergic interneurons and Parkinson's disease.
    Tanimura A; Pancani T; Lim SAO; Tubert C; Melendez AE; Shen W; Surmeier DJ
    Eur J Neurosci; 2018 May; 47(10):1148-1158. PubMed ID: 28677242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.